- | Staging scheme source edition number | Number | 88 | Not applicable (Cases that do not have a recommended staging scheme) | 99 | Unknown edition |
| |
- | Staging scheme source | Number
[1]
| 1 | TNM Classification of Malignant Tumours (UICC) | 2 | Durie & Salmon for multiple myeloma staging | 3 | FAB for leukaemia classification | 4 | Australian Clinico-Pathological Staging (ACPS) System | 8 | Other | 9 | Unknown |
| |
- | Staging basis of cancer | String
[1]
| | |
- | Cancer treatment type | Number
[1]
| 0 | No treatment | 1 | Surgical treatment | 2 | Radiation therapy | 3 | Systemic agent therapy | 4 | Surgical and radiation treatment | 5 | Surgical treatment and systemic agent treatment | 6 | Radiation and systemic agent treatment | 7 | All three treatment types |
| |
- | Intention of treatment for cancer | Number
[1]
| 1 | Prophylactic | 2 | Curative | 3 | Non-curative or palliative | 0 | Did not have treatment | 9 | Not stated |
| DSS specific information: It is used for correlating outcome with original intent of the treatment. |
- | Cancer initial treatment completion date | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: This field must: - be greater than or equal to the date of initial cancer diagnosis, and
- be greater than or equal to the date of the initial course of treatment for cancer.
This item is collected for the analysis of outcome by treatment type. Collecting dates for radiotherapy treatment and systemic therapy agent treatment will allow evaluation of treatments delivered and of time intervals from diagnosis to treatment, from treatment to recurrence and from treatment to death. |
- | Cancer initial treatment starting date | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: This field must: - be greater than or equal to the date of initial cancer diagnosis, and
- be less than or equal to the date on which initial treatment for cancer was completed.
This metadata item is collected for the analysis of outcome by treatment type. Collecting dates for radiotherapy treatment and systemic therapy agent treatment will allow evaluation of treatments delivered and of time intervals from diagnosis to treatment, from treatment to recurrence and from treatment to death. |
- | Outcome of initial treatment | Number
[2]
| 1.0 | Complete response | 2.1 | Partial response | 2.2 | Stable or static disease | 2.3 | Progressive disease | 2.9 | Incomplete response | 9.0 | Not assessed or unable to be assessed |
| DSS specific information: This item is collected for assessing disease status at the end of primary treatment. |
- | Received radiation dose | Number
[5]
| 00000 | No radiation therapy was administered | 99999 | Radiation therapy was administered but the dose is unknown |
| DSS specific information: This item is collected for the analysis of outcome by treatment type. |
- | Radiotherapy treatment type | Number | 1 | External radiotherapy treatment given | 2 | Brachytherapy (radioactive implants) | 3 | Unsealed radioisotopes | 0 | No radiotherapy treatment given | 9 | Radiotherapy was administered but method was not stated |
| DSS specific information: This metadata item is collected for the analysis of outcome by treatment type. |
- | Date of surgical treatment for cancer | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: This field must be greater than or equal to the date of initial cancer diagnosis. This item is collected for analyses of outcome by treatment type. |
- | Surgical treatment procedure for cancer | Number
[7]
| NNNNN-NN The Australian Classification of Health Intervention (7th edition) code set representing procedures. | DSS specific information: This item is collected for determining outcome by treatment type. |
- | Systemic therapy agent name | String
[40]
| X[X(39)]
The Self-instructional manual for tumour registrars: Book 8 code set representing antineoplastic drugs. | DSS specific information: This item is collected for the analysis of outcome by treatment type. |
- | Cancer treatment—target site (ICD-10-AM) | String
[6]
| ANN{.N[N]} The ICD-10-AM (7th edition) code set representing diagnoses. | |
- | Cancer treatment—target site (ICDO-3) | String
[3]
| ANN
The ICDO (3rd edition) code set representing the topography of the cancer. | |
- | Establishment number | Number
[5]
| NNNNN A combination of numeric characters that identify an entity. | |
- | Date of diagnosis of cancer | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Date of diagnosis of first recurrence | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: This field must: - be greater than the date of diagnosis of cancer
- be greater than the cancer initial treatment - completion date (if less than cancer initial treatment - completion date, the patient was never disease-free)
|
- | Address line (person) | String
[180]
| X[X(179)]
A combination of alphanumeric characters. | |
- | Family name | String
[40]
| X[X(39)]
A combination of alphanumeric characters. | |
- | Given name(s) | String
[40]
| X[X(39)]
A combination of alphanumeric characters. | |
- | Cancer staging—M stage code | String
[2]
| | Conditional obligation: Collection of this element is conditional on the disease site being listed in the UICC TNM Classification.DSS specific information: For survival analysis adjusted by stage at diagnosis and distribution of cancer cases by type and stage. |
- | Cancer staging—TNM stage grouping code | String
[7]
| 8888 | Not applicable | 9999 | Unknown, Stage X |
| Conditional obligation: Collection of this element is conditional on the disease site being listed in the UICC TNM Classification.DSS specific information: For survival analysis adjusted by stage at diagnosis and distribution of cancer cases by type and stage. |
- | Histopathological grade | Number
[1]
| 1 | Grade 1: Low grade; well differentiated, differentiated, NOS | 2 | Grade 2: Intermediate grade, moderately differentiated, moderately well differentiated, intermediate differentiation | 3 | Grade 3: High grade, poorly differentiated | 4 | Grade 4: Undifferentiated, anaplastic | 5 | T-cell: T-cell | 6 | B-cell: B-cell, Pre-B, B-Precursor | 7 | Null-cell: Null cell, Non T- non B | 8 | NK-cell: Natural killer cell | 9 | Grade/differentiation unknown: Grade/cell type not determined, not stated or not applicable |
| |
- | Laterality of primary cancer | String
[1]
| R | Right | L | Left | B | Bilateral | N | Not applicable | U | Unknown |
| |
- | Tumour thickness at diagnosis (melanoma) | String
[5]
| | |
- | Morphology of cancer | Number
[5]
| NNNN/N The ICDO (3rd edition) code set representing the histology and behaviour of cancer tissue. | DSS specific information: This information is collected for the purpose of: - classifying tumours into clinically relevant groupings on the basis of both their morphology (cell type) and their degree of invasion or malignancy as indicated by the behaviour code component (the last digit of the morphology code);
- monitoring the number of new cases of cancer for planning treatment services.
|
- | Most valid basis of diagnosis of cancer | Number
[1]
| 0 | Death certificate only: Information provided is from a death certificate | 1 | Clinical: Diagnosis made before death, but without any of the following (codes 2-7) | 2 | Clinical investigation: All diagnostic techniques, including x-ray, endoscopy, imaging, ultrasound, exploratory surgery (e.g. laparotomy), and autopsy, without a tissue diagnosis | 4 | Specific tumour markers: Including biochemical and/or immunological markers that are specific for a tumour site | 5 | Cytology: Examination of cells from a primary or secondary site, including fluids aspirated by endoscopy or needle; also includes the microscopic examination of peripheral blood and bone marrow aspirates | 6 | Histology of metastasis: Histological examination of tissue from a metastasis, including autopsy specimens | 7 | Histology of a primary tumour: Histological examination of tissue from primary tumour, however obtained, including all cutting techniques and bone marrow biopsies; also includes autopsy specimens of primary tumour | 8 | Histology: either unknown whether of primary or metastatic site, or not otherwise specified | 9 | Unknown. |
| DSS specific information: Knowledge of the basis of a diagnosis underlying a cancer code is one of the most important aids in assessing the reliability of cancer statistics. |
- | Regional lymph nodes positive | Number
[3]
| 997 | Number of lymph nodes unknown |
| |
- | Number of regional lymph nodes examined | Number
[3]
| 997 | Number of lymph nodes unknown |
| |
- | Oestrogen receptor assay result | Number
[1]
| 1 | Positive | 2 | Negative | 3 | Equivocal | 7 | Unknown (test results not available) | 8 | Not applicable (test not done) |
| |
- | Primary site of cancer (ICD-10-AM code) | String
[6]
| ANN{.N[N]}
The ICD-10-AM (7th edition) code set representing the site of origin of a tumour, as opposed to the secondary or metastatic sites. | DSS specific information: This information is collected for the purpose of: - classifying tumours into clinically-relevant groupings on the basis of both their site of origin and their histological type
- monitoring the number of new cases of cancer for planning treatment services
- epidemiological studies.
|
- | Primary site of cancer (ICDO-3 code) | String
[6]
| ANN{.N[N]} The ICDO (3rd edition) code set representing the site of origin of a tumour, as opposed to the secondary or metastatic sites. | DSS specific information: This information is collected for the purpose of: - classifying tumours into clinically-relevant groupings on the basis of both their site of origin and their histological type
- monitoring the number of new cases of cancer for planning treatment services
- epidemiological studies.
|
- | Cancer staging—T stage code | String
[3]
| | Conditional obligation: Collection of this element is conditional on the disease site being listed in the UICC TNM Classification.DSS specific information: For survival analysis adjusted by stage at diagnosis and distribution of cancer cases by type and stage. |
- | Progesterone receptor assay results | Number
[1]
| 1 | Test done, results positive (progesterone receptor positive) | 2 | Test done, results negative (Progesterone receptor negative) | 0 | Test not done (test not ordered or not performed) | 8 | Test done but results unknown | 9 | Unknown |
| DSS specific information: Hormone receptor status is an important prognostic indicator for breast cancer. |
- | Region of first recurrence | Number
[1]
| 1 | Local | 2 | Regional | 3 | Both local and regional | 4 | Distant | 5 | Distant and either local or regional | 6 | Local, regional and distant | 0 | None, patient is disease-free | 7 | Patient was never disease-free | 8 | Recurred but site unknown | 9 | Unknown if recurred |
| DSS specific information: This item is collected for the analysis of outcome by treatment type. |
- | Cancer staging—N stage code | String
[2]
| | Conditional obligation: Collection of this element is conditional on the disease site being listed in the UICC TNM Classification.DSS specific information: For survival analysis adjusted by stage at diagnosis and distribution of cancer cases by type and stage. |
- | Tumour size at diagnosis (solid tumours) | String
[3]
| | DSS specific information: This is used to measure the diameter of the largest dimension of breast cancers and other solid neoplasms for patient management, population cancer statistics and research. |
- | Date of birth | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Date of death | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: This field must be greater than or equal to Date of diagnosis of primary cancer. |
- | Medicare card number | Number
[11]
| N(11) A combination of numeric characters that uniquely identify a Medicare customer. | |
- | Person identifier | String
[20]
| XXXXXX[X(14)]
A logical combination of valid alphanumeric characters that identify an entity. | |
- | Sex | Number
[1]
| 1 | Male | 2 | Female | 3 | Intersex or indeterminate | 9 | Not stated/inadequately described |
| |
- | Sex | Number
[1]
| 1 | Male | 2 | Female | 3 | Intersex or indeterminate | 9 | Not stated/inadequately described |
| |